![John B. Hoopingarner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John B. Hoopingarner
Chief Operating Officer at
Receptor Logic, Inc.
Profile
John B. Hoopingarner is currently the Chief Operating Officer at Receptor Logic, Inc. and Pure Protein LLC.
He previously held positions as the Executive Vice President at Emergent Technologies, Inc., Chief Operating Officer at Mimetic Solutions LLC, Chief Operating Officer at Heparinex LLC from 2009 to 2010, Chief Operating Officer at Hyalose LLC, Chief Operating Officer at Choncept LLC, and Principal at AeonClad Coatings LLC.
He obtained his undergraduate degree from Southern Methodist University.
John B. Hoopingarner active positions
| Companies | Position | Start |
|---|---|---|
Receptor Logic, Inc.
 Receptor Logic, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies and pharmaceutical products | Chief Operating Officer | - |
Pure Protein LLC
 Pure Protein LLC Pharmaceuticals: MajorHealth Technology Specializes in immunology tools for diagnostics, drug and vaccine development | Chief Operating Officer | 2009-07-28 |
Former positions of John B. Hoopingarner
| Companies | Position | End |
|---|---|---|
Emergent Technologies, Inc.
 Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies invests in companies located in the United States. The firm focuses on life sciences and technology sectors and industries. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
AeonClad Coatings LLC
 AeonClad Coatings LLC Medical SpecialtiesHealth Technology Develops plasma coating for medical devices and other specialty products | Corporate Officer/Principal | - |
Choncept LLC
 Choncept LLC Pharmaceuticals: MajorHealth Technology Produces biotechnology products | President | - |
Hyalose LLC
 Hyalose LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | President | - |
Mimetic Solutions LLC
 Mimetic Solutions LLC Pharmaceuticals: MajorHealth Technology Develops and distributes drugs & chemicals | Chief Operating Officer | - |
Training of John B. Hoopingarner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent Technologies, Inc.
Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies invests in companies located in the United States. The firm focuses on life sciences and technology sectors and industries. It provides financing for early stage capital requirements. | Finance |
Mimetic Solutions LLC
Mimetic Solutions LLC Pharmaceuticals: MajorHealth Technology Develops and distributes drugs & chemicals | Health Technology |
Heparinex LLC
 Heparinex LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Receptor Logic, Inc.
Receptor Logic, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies and pharmaceutical products | Health Technology |
Hyalose LLC
Hyalose LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Choncept LLC
Choncept LLC Pharmaceuticals: MajorHealth Technology Produces biotechnology products | Health Technology |
AeonClad Coatings LLC
AeonClad Coatings LLC Medical SpecialtiesHealth Technology Develops plasma coating for medical devices and other specialty products | Health Technology |
Pure Protein LLC
Pure Protein LLC Pharmaceuticals: MajorHealth Technology Specializes in immunology tools for diagnostics, drug and vaccine development | Health Technology |
- Stock Market
- Insiders
- John B. Hoopingarner
